# Addus HomeCare Corp: overview

ADUS · Nasdaq · CIK 1468328 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/adus.md) · [Financials](/companies/adus/financials.md) · [Filings](/companies/adus/filings.md) · [Insiders](/companies/adus/insiders.md)

Latest reported revenue: [$377.4m](/filings/0001437749-26-025678.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 4, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001437749-26-025678).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [290](/filings/0001437749-25-033041.md) | [297 d](/filings/0001437749-26-005352.md) | [338](/filings/0001437749-26-014900.md) | [349](/filings/0001437749-26-025678.md) | [362](/filings/0001437749-25-033041.md) | [373 d](/filings/0001437749-26-005352.md) | [364](/filings/0001437749-26-014900.md) | [377](/filings/0001437749-26-025678.md) |
| Gross margin | % | [31.8%](/filings/0001437749-25-033041.md) | [34.2% d](/filings/0001437749-26-005352.md) | [31.9%](/filings/0001437749-26-014900.md) | [32.6%](/filings/0001437749-26-025678.md) | [32.2%](/filings/0001437749-25-033041.md) | [33.1% d](/filings/0001437749-26-005352.md) | [31.9%](/filings/0001437749-26-014900.md) | [32.2%](/filings/0001437749-26-025678.md) |
| Operating margin | % | [9.0%](/filings/0001437749-25-033041.md) | [9.1% d](/filings/0001437749-26-005352.md) | [9.0%](/filings/0001437749-26-014900.md) | [9.4%](/filings/0001437749-26-025678.md) | [9.1%](/filings/0001437749-25-033041.md) | [11.3% d](/filings/0001437749-26-005352.md) | [9.4%](/filings/0001437749-26-014900.md) | [10.3%](/filings/0001437749-26-025678.md) |
| Net margin | % | [7.0%](/filings/0001437749-25-033041.md) | [6.6% d](/filings/0001437749-26-005352.md) | [6.3%](/filings/0001437749-26-014900.md) | [6.3%](/filings/0001437749-26-025678.md) | [6.3%](/filings/0001437749-25-033041.md) | [8.0% d](/filings/0001437749-26-005352.md) | [6.9%](/filings/0001437749-26-014900.md) | [7.3%](/filings/0001437749-26-025678.md) |
| Diluted EPS | $ per share | [1.10](/filings/0001437749-25-033041.md) | not reported | [1.16](/filings/0001437749-26-014900.md) | [1.20](/filings/0001437749-26-025678.md) | [1.24](/filings/0001437749-25-033041.md) | not reported | [1.36](/filings/0001437749-26-014900.md) | [1.49](/filings/0001437749-26-025678.md) |
| Free cash flow | $m | [46.6 d](/filings/0001437749-25-033041.md) | [8.7 d](/filings/0001437749-26-005352.md) | [17.1](/filings/0001437749-26-014900.md) | [21.3 d](/filings/0001437749-26-025678.md) | [49.3 d](/filings/0001437749-25-033041.md) | [16.1 d](/filings/0001437749-26-005352.md) | [50.7](/filings/0001437749-26-014900.md) | [38.7 d](/filings/0001437749-26-025678.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [864](/filings/0000950170-24-021284.md) | [951](/filings/0000950170-25-026747.md) | [1,059](/filings/0001437749-26-005352.md) | [1,155](/filings/0001437749-26-005352.md) | [1,423](/filings/0001437749-26-005352.md) |
| Gross margin | % | [31.2%](/filings/0000950170-24-021284.md) | [31.5%](/filings/0000950170-25-026747.md) | [32.1%](/filings/0001437749-26-005352.md) | [32.5%](/filings/0001437749-26-005352.md) | [32.5%](/filings/0001437749-26-005352.md) |
| Operating margin | % | [7.6%](/filings/0000950170-24-021284.md) | [7.2%](/filings/0000950170-25-026747.md) | [8.6%](/filings/0001437749-26-005352.md) | [8.9%](/filings/0001437749-26-005352.md) | [9.7%](/filings/0001437749-26-005352.md) |
| Net margin | % | [5.2%](/filings/0000950170-24-021284.md) | [4.8%](/filings/0000950170-25-026747.md) | [5.9%](/filings/0001437749-26-005352.md) | [6.4%](/filings/0001437749-26-005352.md) | [6.7%](/filings/0001437749-26-005352.md) |
| Diluted EPS | $ per share | [2.81](/filings/0000950170-24-021284.md) | [2.84](/filings/0000950170-25-026747.md) | [3.83](/filings/0001437749-26-005352.md) | [4.23](/filings/0001437749-26-005352.md) | [5.22](/filings/0001437749-26-005352.md) |
| Free cash flow | $m | [34.8](/filings/0000950170-24-021284.md) | [96.8](/filings/0000950170-25-026747.md) | [103](/filings/0001437749-26-005352.md) | [110](/filings/0001437749-26-005352.md) | [104](/filings/0001437749-26-005352.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/adus/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $344.2m | 3,425,435 |  | Added +335,205 |
| [Capital Research Global Investors](/funds/1422848.md) | 2026-06-30 | $139.6m | 1,389,907 |  | Reduced −145,417 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $83.9m | 835,163 |  | Added +91,036 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $79.3m | 789,325 |  | Added +4,914 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $78.1m | 777,826 |  | Added +56,579 |
| [SILVERCREST ASSET MANAGEMENT GROUP LLC](/funds/1232395.md) | 2026-06-30 | $69.4m | 691,246 |  | Reduced −37,950 |
| [WASATCH ADVISORS LP](/funds/814133.md) | 2026-06-30 | $68.4m | 680,926 |  | Reduced −186,899 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $56.7m | 564,637 |  | Added +246,312 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $51.8m | 515,525 |  | Added +33,995 |
| [PRINCIPAL FINANCIAL GROUP INC](/funds/1126328.md) | 2026-06-30 | $41.3m | 411,563 |  | Reduced −22,908 |

## Recent filings

[All 960 filings](/companies/adus/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-14 | 17:05 ET | [8-K](/filings/0001437749-26-030348.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-030348 |
| 2026-08-13 | 16:16 ET | [8-K](/filings/0001437749-26-027682.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-027682 |
| 2026-08-04 | 16:30 ET | [10-Q](/filings/0001437749-26-025678.md) | Quarterly report, period 2026-06-30 | 0001437749-26-025678 |
| 2026-08-03 | 16:25 ET | [8-K](/filings/0001437749-26-025448.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-025448 |
| 2026-06-10 | 16:03 ET | [8-K](/filings/0001437749-26-020152.md) | 5.07 Shareholder vote results | 0001437749-26-020152 |
| 2026-05-05 | 16:30 ET | [10-Q](/filings/0001437749-26-014900.md) | Quarterly report, period 2026-03-31 | 0001437749-26-014900 |
| 2026-05-04 | 16:15 ET | [8-K](/filings/0001437749-26-014653.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-014653 |
| 2026-04-23 | 16:31 ET | [DEF 14A](/filings/0001437749-26-013190.md) | Proxy statement, period 2026-06-10 | 0001437749-26-013190 |
| 2026-03-12 | 16:31 ET | [10-K/A](/filings/0001437749-26-007982.md) | Annual report, amended, period 2025-12-31 | 0001437749-26-007982 |
| 2026-02-24 | 16:31 ET | [10-K](/filings/0001437749-26-005352.md) | Annual report, period 2025-12-31 | 0001437749-26-005352 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001437749-26-005352.md), filed Feb 24, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/cb55eadf-af81-4cb5-9ea4-6a735fa155fa)

## About the filer

- CIK: 1468328
- Tickers: ADUS
- Exchange: Nasdaq
- SIC code: 8082 Services-Home Health Care Services
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.